Effect of pioglitazone on vascular reactivity in vivo and in vitro

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 270, Issue 3 39-3, 1996, Pages

  Kotchen, Theodore A ^a   Zhang, Hong Yan ^a   Reddy, Sreenivas ^a   Hoffmann, Raymond G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Dahl salt sensitive rats; hypertension; insulin sensitivity; vasoconstriction; vasodilation

Indexed keywords

ANGIOTENSIN; GLUCOSE; INSULIN; NORADRENALIN; PIOGLITAZONE;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERTENSION; INSULIN SENSITIVITY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 13344282090     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.270.3.r660     Document Type: Article

References (34)

1. Alexander, W. D., R. J. Oake. The effect of insulin an vascular reactivity to norepinephrine. Diabetes 26: 611-614, 1977.
2. erson, E. A., A. L. Mark. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension Dallas 21: 136-141, 1993.
3. Buchanan, T. A., W. P. Meehan, Y. Y. Jeng, D. Yang, T. M. Chan, J. L. Nadler, S. Scott, R. K. Rude, and W. A. Hseuh. Blood pressure lowering by pioglitazone: evidence for a direct vascular effect. J. Clin. Invest. 96: 354-460, 1995.
4. Dubey, R. K., H. Y. Zhang, S. R. Reddy, M. A. Boegehold, and T. A. Kotchen. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R726-R732, 1993.
5. Gaboury, C. L., D. C. Simonson, E. W. Seely, N. K. Hollenberg, and G. H. Williams. Relation of pressure responsiveness to angiotensin II and insulin resistance in hypertension. J. Clin. Invest. 94: 2295-2300, 1994.
6. Gans, R. O. B., H. J. G. Bilo, W. W. A. Maarschallkerweerd, R. J. Heine, J. J. P. Nauta, and A. J. M. Donker. Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II. J. Clin. Invest. 88: 512-518, 1991.
7. Govindarajuiu, Z. Statistical Technique in Bioassay. Basel, Switzerland: Karger, 1988, p. 28-64.
8. Gros, R., K. R. Borkowski, and R. D. Feldman. Human insulin-mediated enhancement of vascular beta adrenergic responsiveness. Hypertension Dallas 23: 551-555, 1994.
9. Hall, J. E., R. L. Summers, M. W. Brands, H. Keen, and M. Alons-Galicia. Resistance to metabolic actions of insulin and its role in hypertension. Am. J. Hypertens. 7: 772-788, 1994.
10. Jern, S. Effects of insulin on vascular responses to mental stress and norepinephrine in human forearm. Hypertension Dallas 24: 686-694, 1994.
11. Kahn, A., C. L. Seidel, J. C. Allen, R. G. O'Neil, H. Shelat, and T. Song. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension Dallas 22: 735-742, 1993
12. Kaiser, N., S. Sasson, E. P. Feener, N. Boukobza-Vardi, S. Higashi, D. E. Moller, S. Davidheisser, R. J. Przybyski, and G. L. King. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42: 80-89, 1993.
13. Kaufman, L. N., M. M. Peterson, and L. M. DeGrange. Pioglitazone prevents diet induced hypertension in rats (Abstract). Diabetes 42: 47A, 1993.
14. Kotchen, T. A. Attenuation of experimental hypertension with agents that increase insulin sensitivity. Drug Dev. Res. 32: 100-103, 1994.
15. Kotchen, T. A., G. P. Guthrie. Renin-angiotensin-aldosterone, and hypertension. Endocr. Rev. 1: 78-99, 1980.
16. Kotchen, T. A., H. Y. Zhang, M. Covelli, and N. Blehschmidt. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats. Am. J. Physiol. 261 (Endocrinol. Metab. 24): E692-E697, 1991.
17. Laakso, M., S. V. Edelman, G. Brechtel, and A. D. Baron. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J. Clin. Invest. 85: 1844-1852, 1990.
18. Meier, D. A., C. W. Garner. Estradiol stimulation of glucose transport in rat uterus. Endocrinology 121: 1366-1374, 1987.
19. Pershadsingh, H. A., J. Szollosi, S. Benson, W. C. Hyun, B. G. Feuerstein, and T. W. Kurtz. Effect of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension Dallas 21: 1020-1023, 1993.
20. Reaven, G. M., H. Chang, B. B. Hoffman, and S. Azhar. Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 38: 1155-1160, 1989.
21. Scherrer, U., D. Randin, L. Vollenweider, and P. Nicod. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 94: 2511-2515, 1994.
22. Soltis, E. E., D. F. Bohr. Vascular reactivity in the spontaneously hypertensive stroke-prone rat: effect of antihypertensive treatment. Hypertension Dallas 9: 492-497, 1987.
23. Soltis, E. E., M. J. Katovich. Reduction in aortic smooth muscle beta-adrenergic responsiveness results in enhanced norepinephrine responsiveness in the Dahl salt-sensitive rat (Abstract). Clin. Exp. Hypertens. A13: 117-132, 1991.
24. Sowers, J., P. R. Standley, and J. L. Ram. Insulin resistance, carbohydrate metabolism, and hypertension. Am. J. Hypertens 4: 466S-472S, 1991.
25. Standley, P. R., K. A. Rose, and J. Sowers. Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am. J. Hypertens. 8: 48-52, 1995.
26. Townsend, R. R., R. Yamamoto, M. Nickols, D. J. DiPette, and G. A. Nichols. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension Dallas 19, Suppl. I: II-105-II-110, 1992.
27. Vollenweider, P., D. Randin, L. Tappy, E. Jequier, P. Nicod, and U. Scherrer. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans J. Clin. Invest. 93: 2365-2371, 1994.
28. Wambach, G. K., D. Liu. Insulin attenuates vasoconstriction induced by noradrenaline, serotonin and potassium chloride in rat mesenteric resistance arteries. Clin. Exp. Hypertens. A 14: 733-740, 1991.
29. Yagi, S., S. Takata, H. Kiyokawa, K. Yamamoto, Y. Noto, T. Ikeda, N. Hattori. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 37: 1064-1067, 1988.
30. Yoshioka, S., H. Nishino, T. Shiraki, K. Ikeda, H. Koike, A. Okuno, M. Wada, T. Fujiwara, and H. Hoskioshi. Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metabolism 42: 75-80, 1993.
31. 2+-ATPase. Am. J Hypertens. 5: 637-641, 1992.
32. Zemel, M. B., S. Reddy, and J. Sowers. Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am. J. Hypertens. 4: 537-539, 1991.
33. Zhang, H. Y., S. R. Reddy, and T. A. Kotchen. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension Dallas 24: 106-110, 1994.
34. Zhang, F., J. Sowers, J. L. Ram, P. R. Standley, and J. D. Peuler. Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension Dallas 24: 170-175, 1994